Clinical Trial Update: Effects of Administration of Fostamatinib on Blood Concentrations of Digoxin in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated whether fostamatinib affects blood concentrations of digoxin in healthy volunteers and in subjects with rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• DIGOXIN (Digoxin)
• Fostamatinib (fostamatinib)

Snippet

Sponsor: AstraZeneca | Conditions: Healthy Volunteers, Rheumatoid Arthritis | Phase 1 | Status: COMPLETED